ESH Video

9th Translational Research Conference: Myeloproliferative Neoplasms

9th Translational Research Conference: Myeloproliferative Neoplasms
May 12 - May 15, 2022 - E-CONFERENCE, #ESHMPN2022
Chairs : Jean-Jacques Kiladjian, Ross Levine, Alessandro Vannucchi

Information

9th Translational Research Conference:
MYELOPROLIFERATIVE NEOPLASMS

GOING VIRTUAL!
New dates: May 12-15, 2022  – E-Conference

#ESHMPN2022

CHAIRS: Jean-Jacques Kiladjian, Ross Levine, Alessandro Vannucchi

 


 

In view of continuing COVID-19 related challenges and uncertainties,
the ESH 9th Translational Research Conference:
MYELOPROLIFERATIVE NEOPLASMS

will be held as a VIRTUAL EVENT.

The safety of our speakers and attendees comes first.
We successfully transformed our last 16 conferences into E-Conferences
and will place you in the best dispositions to enjoy the presentations and discussions.

Participants will be joining us from all over the world and from different time zones.
To make sure that everyone has access to the full scientific programme
at a convenient hour, registration will allow participants to join both
the LIVE PROGRAMME: May 12-15, 2022
and the PROGRAMME ON-DEMAND: May 3 – June 15, 2022

REGISTRATION IS OFFERED FREE OF CHARGE
as a gesture of solidarity during these difficult times.

 



About the Conference:

New insights into the molecular pathogenesis, classification, and management of patients with Myeloproliferative Neoplasms (MPN) have arisen at increasing pace during the past years. This International Conference brings together scientists and clinicians to present and discuss new data on the cellular and molecular biology of these disorders as well as their diagnosis and treatment.

The field of MPN research is rapidly expanding and consequently treatment options are changing. Clinical and laboratory investigators involved in the care of MPN patients or in research on the biology of these diseases will profit from hearing international leaders present the newest biological, clinical and therapeutic developments in the field.
The format of the scientific programme is deliberately designed to be conducive to close scientific interaction between speakers and registered participants from all over the world.

Topics:
• Molecular pathogenesis of MPNs
• Novel MPN therapeutics
• MPN initiation and clonal evolution
• Murine MPN models and pathogenesis/therapeutic studies
• Molecular pathogenesis and therapy of MPN progression and leukaemic transformation
• Recent advances in therapeutics

This meeting will be valuable to you if you are looking for:
• A cutting-edge scientific programme – from basic science to clinical and therapeutic applications and perspectives.
• An emphasis on in-depth scientific discussion
• Opportunities for informal face-to-face scientific interaction with global authorities in the field.

The meeting will be of interest to:
• Senior biologists and clinicians, including experts in the field (MD, PhD, MD-PhD)
• Junior scientists and clinicians (MD, PhD)
• PhD candidates and clinical residents still in-training

 Learning Objectives:
• To understand the newest discoveries on the molecular pathogenesis of MPN
• To appreciate recent changes in treatment recommendations for MPN patients including the evolving landscape of approved therapies
• To gain insight into ongoing clinical trials investigating novel agents for MPN treatment
• To increase knowledge about cellular and animal models of MPN and their use for drug screening

 The programme will include:
• Keynote Lectures
• Plenary Sessions
• Simultaneous Meet the Expert Sessions
• Mentored Poster Walks
• Short Oral Communications
• Ample time for in-depth discussion

 

 

Programme

Click here to access the final programme.

LIVE PROGRAMME: May 12-15, 2022 CEST
PROGRAMME ON-DEMAND: May 3 – June 15, 2022

Click here to access the on-demand programme.

Abstract submission

SUBMISSION OF ABSTRACTS IS NOW CLOSED.

 

Abstracts guidelines:

– Your abstract has to be structured (eg Objectives, Methods, Results, Conclusions)

– Maximum number of words: 500

– Your abstract will be submitted to the peer review procedure.

The following file types may be uploaded: HTML document (*.htm), HTML document (*.html), JPEG image (*.jpg), GIF image (*.gif), or PNG image (*.png).

 

Symposia

Accommodation

N/A

Venue

The E-Conference platform is now open!

Take a virtual tour and make yourself at home:

 

 

To access the platform click here!

 

Corporate partners

With the support of*:

 

BMS

Morphosys

Level 1 E-Conference Partners
*******

 

Level 2 E-Conference Partners
*******

 

Supporting E-Conference Partners
*******

 

*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.

Scholarships

ESH SCHOLARSHIP FUND

 

MPN RESEARCH FOUNDATION SCHOLARSHIPS

 

ESH extends thanks to the MPN Research Foundation for its continuous support to the ESH Scholarship Fund
 
 
 

Workshop

Educational Grants

Registration

The registration for the ESH 9th Translational Research Conference on Myeloproliferative Neoplasms is offered FREE OF CHARGE, as a gesture of solidarity during these difficult times.

REGISTRATION IS OPEN!

 

Meet the Expert sessions: Registration fee: 20€
These sessions will be open to E-Conference academic biologists and clinicians registrants only. A maximum of 30 seats will be available in each session and pre-registration will therefore be required.

 

Register Here